View of Decrease of Epstein-Barr Virus Anti Early Antigen Imunoglobulin a Levels and Primary Tumor Size in PostCisplatin-Paclitaxel Chemotherapy in Nasopharyngeal Carcinoma Patients

Return to Article Details Decrease of Epstein-Barr Virus Anti Early Antigen Imunoglobulin a Levels and Primary Tumor Size in PostCisplatin-Paclitaxel Chemotherapy in Nasopharyngeal Carcinoma Patients Download Download PDF